tradingkey.logo
tradingkey.logo
Search

Agilent Technologies Inc

A
Add to Watchlist
110.570USD
-1.540-1.37%
Close 05/19, 16:00ETQuotes delayed by 15 min
31.25BMarket Cap
24.30P/E TTM

Agilent Technologies Inc

110.570
-1.540-1.37%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Agilent Technologies Inc

Currency: USD Updated: 2026-05-19

Key Insights

Agilent Technologies Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered undervalued, ranking 61 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 161.14.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Agilent Technologies Inc's Score

Industry at a Glance

Industry Ranking
61 / 205
Overall Ranking
149 / 4473
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

20°C

Very Low
Very High
Neutral

Agilent Technologies Inc Highlights

StrengthsRisks
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.55%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 21.55%.
Undervalued
The company’s latest PE is 24.30, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 245.79M shares, decreasing 8.27% quarter-over-quarter.
Held by Keeley-Teton Advisors, LLC
Star Investor Keeley-Teton Advisors, LLC holds 7.00K shares of this stock.

Analyst Rating

Based on 21 analysts
Buy
Current Rating
161.138
Target Price
+44.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-19

The current financial score of Agilent Technologies Inc is 7.27, ranking 77 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.80B, representing a year-over-year increase of 6.96%, while its net profit experienced a year-over-year increase of 4.09%.

Score

Industry at a Glance

Previous score
7.27
Change
0

Financials

6.02

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.18

Operational Efficiency

7.14

Growth Potential

7.93

Shareholder Returns

8.07

Agilent Technologies Inc's Company Valuation

Currency: USD Updated: 2026-05-19

The current valuation score of Agilent Technologies Inc is 6.45, ranking 157 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 24.30, which is 438.09% below the recent high of 130.76 and 6.57% above the recent low of 22.71.

Score

Industry at a Glance

Previous score
6.45
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 61/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-19

The current earnings forecast score of Agilent Technologies Inc is 7.90, ranking 113 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 167.50, with a high of 185.00 and a low of 149.86.

Score

Industry at a Glance

Previous score
7.91
Change
-0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 21 analysts
Buy
Current Rating
161.138
Target Price
+44.26%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Agilent Technologies Inc
A
21
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-19

The current price momentum score of Agilent Technologies Inc is 6.49, ranking 140 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 119.18 and the support level at 106.08, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.69
Change
-0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.866
Sell
RSI(14)
40.868
Neutral
STOCH(KDJ)(9,3,3)
9.162
Oversold
ATR(14)
3.450
Low Volatility
CCI(14)
-103.569
Sell
Williams %R
96.329
Oversold
TRIX(12,20)
-0.139
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
112.076
Sell
MA10
113.670
Sell
MA20
114.435
Sell
MA50
114.754
Sell
MA100
123.623
Sell
MA200
129.401
Sell

Institutional Confidence

Currency: USD Updated: 2026-05-19

The current institutional shareholding score of Agilent Technologies Inc is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 86.97%, representing a quarter-over-quarter decrease of 8.35%. The largest institutional shareholder is Invesco, holding a total of 1.89M shares, representing 0.67% of shares outstanding, with 1.55% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
14.70M
-1.69%
MFS Investment Management
13.17M
+14.41%
State Street Investment Management (US)
12.68M
+1.94%
T. Rowe Price Investment Management, Inc.
8.14M
-0.05%
Wellington Management Company, LLP
7.59M
-19.09%
Geode Capital Management, L.L.C.
7.43M
+0.34%
DWS Investment GmbH
4.53M
-0.43%
State Farm Insurance Companies
4.52M
--
1
2

Risk Assessment

Currency: USD Updated: 2026-05-19

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Agilent Technologies Inc is 8.87, ranking 15 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.21. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
8.87
Change
0
Beta vs S&P 500 index
1.21
VaR
+2.91%
240-Day Maximum Drawdown
+29.87%
240-Day Volatility
+29.47%

Return

Best Daily Return
60 days
+4.77%
120 days
+4.77%
5 years
+8.72%
Worst Daily Return
60 days
-5.02%
120 days
-5.02%
5 years
-9.66%
Sharpe Ratio
60 days
-1.35
120 days
-2.24
5 years
-0.08

Risk Assessment

Maximum Drawdown
240 days
+29.87%
3 years
+35.79%
5 years
+44.62%
Return-to-Drawdown Ratio
240 days
-0.13
3 years
-0.06
5 years
-0.13
Skewness
240 days
+0.38
3 years
+0.15
5 years
+0.17

Volatility

Realised Volatility
240 days
+29.47%
5 years
+31.49%
Standardised True Range
240 days
+3.00%
5 years
+3.11%
Downside Risk-Adjusted Return
120 days
-352.11%
240 days
-352.11%
Maximum Daily Upside Volatility
60 days
+24.30%
Maximum Daily Downside Volatility
60 days
+28.40%

Liquidity

Average Turnover Rate
60 days
+0.79%
120 days
+0.76%
5 years
--
Turnover Deviation
20 days
+3.47%
60 days
+17.23%
120 days
+13.10%

Peer Comparison

Healthcare Equipment & Supplies
Agilent Technologies Inc
Agilent Technologies Inc
A
7.25 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.41 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI